CHEMMNasdaq CopenhagenMedical DevicesIFRS · DKK

CHEMOMETEC A/S

CHEMOMETEC A/S designs and sells advanced cell counting and analysis instruments used in laboratories to measure cells, viability, and concentration. The company is based in Allerød, Denmark, and serves life science and biopharma customers through its own product portfolio and related consumables and services.

Kysy yhtiöstä
Liikevaihto249milj. DKK
−1,0 %v/v
Liikevoitto (EBIT)121milj. DKK
−4,3 %v/v
EBIT-marginaali48,4%
−1,7 %-yks.v/v
Nettotulos94,0milj. DKK
−9,1 %v/v
Vapaa kassavirta79,3milj. DKK
+2,1 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2020–2025

0100200300400500milj. DKK2020: 281 milj. DKK2020: EBIT 116 milj. DKK20202021: 427 milj. DKK2021: EBIT 203 milj. DKK20212022: 241 milj. DKK2022: EBIT 135 milj. DKK20222023: 199 milj. DKK2023: EBIT 85 milj. DKK20232024: 251 milj. DKK2024: EBIT 126 milj. DKK20242025: 249 milj. DKK2025: EBIT 121 milj. DKK2025249121
LiikevaihtoLiikevoitto (EBIT)
Kysy Clarifolta: CHEMOMETEC A/S

Liiketoiminta

Osuus liikevaihdosta
Cell counting instruments70 %

Desktop and automated instruments used to count and analyze cells and viability.

Consumables20 %

Disposable slides and related items required for routine instrument use.

Services and support10 %

Installation, training, and technical support linked to instrument deployments.

Asiakkaat

Chemometec sells primarily to laboratories that need fast, reproducible cell counts for research, development, and quality workflows. Its customer base includes biopharma companies, academic and research labs, and other life science organizations that use cell analysis in routine and specialized applications.

Biopharma R&D

Buys instruments and consumables for cell line development, assay work, and process development.

Academic and research institutions

Uses the systems for routine cell counting and experimental workflows.

Life science quality labs

Purchases instruments for QC and standardized sample handling.

Strategia

Chemometec’s business depends on expanding its installed base of instruments and keeping those customers active in consumables and support purchases. Strategic execution therefore centers on product performance, workflow reliability, and maintaining relevance in laboratory automation and cell analysis workflows.

Installed-base expansionKeskipitkä aikaväli

More installed instruments create long-term consumables and service demand.

Consumables attachmentLyhyt aikaväli

Recurring slide sales strengthen the revenue model after instrument placement.

Product performance and workflow fitPitkä aikaväli

Accuracy and ease of use influence adoption in regulated and research settings.

Maantiede

The company is headquartered in Denmark and operates internationally through a life-science sales footprint. Its demand base is concentrated in markets with strong biotechnology, pharmaceutical, and research activity, so geography matters for both distribution reach and exposure to local lab spending cycles.

Riskit

Chemometec is exposed to demand cycles in biotechnology and research spending, which can affect instrument orders and timing of consumables usage. The business also depends on product performance, competition in laboratory instrumentation, and execution in global sales and support, all of which can influence adoption and customer retention.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Biotech and research budget cyclicality1Product performance and quality risk2Competitive pressure3
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Biotech and research budget cyclicalityVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Instrument demand depends on customer capital spending and lab expansion activity.

    Kohdistuu: Instrument sales timing

  2. Product performance and quality riskVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Measurement accuracy and reliability are central to customer adoption.

    Kohdistuu: Reputation and repeat purchases

  3. Competitive pressureVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Laboratory instrumentation markets can attract established and niche competitors.

    Kohdistuu: Pricing and market share

Kysy Clarifolta: CHEMOMETEC A/S

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition

Instrument, consumable, and service elements may be recognized differently depending on contract terms.

Vaikutus: Affects revenue timing and mix

Inventory valuation

Hardware and consumables require stock that may need obsolescence or write-down testing.

Vaikutus: Affects gross profit and working capital

Warranty provisions

Instrument sales can create future repair or replacement obligations.

Vaikutus: Affects operating expenses and liabilities

Foreign exchange translation

International revenue and costs may be denominated in multiple currencies.

Vaikutus: Affects reported earnings and equity

Samankaltaisia listattuja yhtiöitä

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Cytek Biosciences, Inc.

CTKB · Laboratory Analytical Instruments

Century Therapeutics, Inc.

IPSC · Biological Products, (No Diagnostic Substances)

CellaVision

CEVI · Health Care

Advanced Biomed Inc.

ADVB · Services-Medical Laboratories

CytoMed Therapeutics Ltd

GDTC · Pharmaceutical Preparations

ASTROTECH Corp

ASTC · Laboratory Analytical Instruments

Päivitetty: 24.10.2026